Irati
Garmendia Iturbe
Forscherin bis um 2019
Teresa
Lozano Moreda
Profesional Investigadora
Publikationen, an denen er mitarbeitet Teresa Lozano Moreda (1)
2021
-
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3